Paroxysmal Nocturnal Hemoglobinuria - 28 Studies Found
Recruiting |
: Phase 2 Safety and Efficacy Study of RA101495 to Treat PNH Patients Who Have an Inadequate Response to Eculizumab : Paroxysmal Nocturnal Hemoglobinuria (PNH) : 2017-01-20 : Drug: RA101495 0.3mg/kg subcutaneously (SC) at Day 1 (loading dose) followed by a starting maintenance d |
Completed |
: Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) : Paroxysmal Hemoglobinuria, Nocturnal : 2005-07-20 :
|
Completed |
: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria : Paroxysmal Hemoglobinuria, Nocturnal : 2005-08-11 : Drug: Eculizumab |
Active, not recruiting |
: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria :
: |
Active, not recruiting |
: Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria :
: 1999-10-18 :
|